Sumitomo Mitsui Trust Holdings Inc. Purchases Shares of 48,485 Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 48,485 shares of the company’s stock, valued at approximately $843,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of CCAP. SG Americas Securities LLC bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth about $197,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Crescent Capital BDC in the 3rd quarter worth about $240,000. Silverberg Bernstein Capital Management LLC bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth about $248,000. Jump Financial LLC increased its holdings in shares of Crescent Capital BDC by 4.6% in the 3rd quarter. Jump Financial LLC now owns 19,559 shares of the company’s stock worth $334,000 after buying an additional 859 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new stake in shares of Crescent Capital BDC in the 4th quarter worth about $342,000. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Price Performance

CCAP stock opened at $17.24 on Friday. Crescent Capital BDC, Inc. has a 12 month low of $13.11 and a 12 month high of $18.00. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.14. The company has a 50-day moving average price of $17.04 and a 200 day moving average price of $16.79. The stock has a market cap of $638.91 million, a PE ratio of 7.53 and a beta of 0.83.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last released its quarterly earnings results on Wednesday, February 21st. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. Crescent Capital BDC had a net margin of 45.54% and a return on equity of 11.32%. The firm had revenue of $50.00 million during the quarter, compared to analysts’ expectations of $47.99 million. Equities research analysts anticipate that Crescent Capital BDC, Inc. will post 2.26 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Friday, March 29th were paid a dividend of $0.41 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 9.51%. Crescent Capital BDC’s dividend payout ratio is presently 71.62%.

Analyst Upgrades and Downgrades

CCAP has been the topic of a number of research reports. Wells Fargo & Company boosted their target price on shares of Crescent Capital BDC from $16.00 to $16.50 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Oppenheimer boosted their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a report on Friday, February 23rd.

Check Out Our Latest Analysis on CCAP

Crescent Capital BDC Profile

(Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report).

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.